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Abstract 
Background: Lysine‑specific histone demethylase 1 (LSD1) modulates chromatin status through demethylation of 
H3K4 and H3K9. It has been demonstrated that LSD1 is hyperphosphorylated and dissociates from chromatin during 
mitosis. However, the molecular mechanism of LSD1 detachment is unknown.
Results: In this report, we found that polo‑like kinase 1 (PLK1) directly interacted with LSD1 and phosphorylated 
LSD1 at Ser‑126 . Nocodazole‑induced metaphase arrest promoted release of LSD1 from chromatin, and the phos‑
phorylation‑defective mutant LSD1 (S126A) failed to dissociate from chromatin upon nocodazole treatment.
Conclusions: Taken together, our findings demonstrate that phosphorylation of LSD1 at Ser‑126 by PLK1 promotes 
its release from chromatin during mitosis.
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Background
Histone post-translational modifications (PTMs) serve 
as major regulatory mechanisms for chromatin structure 
and function [1]. While the presence of methylation and 
acetylation [2] and phosphorylation [3] on histones was 
described about half a century ago, many more PTMs 
have been demonstrated to occur on histones [4]. Given 
that chromatin dynamics plays an essential role both 
in maintenance of cellular homeostasis and in cellular 
stress responses, histone PTMs have been implied in 
most, if not all physiological and pathological processes. 
However, the biological significance and the molecular 
mechanism of these PTMs, particularly the crosstalk and 
joint effects of different PTMs on the same molecule, are 
largely elusive, and deciphering the regulatory networks 
of the protein machineries that incorporate (write), 
remove (erase), and bind (read) histone PTMs is of high 
interest.
Lysine-specific demethylase 1 (LSD1), a flavin adenine 
dinucleotide (FAD)-dependent amine oxidase, was the 
first identified demethylase (eraser) for lysine meth-
ylation of histones and non-histone proteins [5]. It spe-
cifically removes methyl groups via a redox process of 
mono- or di-methylated histone H3 lysine4 (H3K4) [6] 
and H3 lysine 9 (H3K9) [7]. LSD1 in the CoREST-HDAC 
containing repressor complexes, functions as a corepres-
sor by mediating demethylation of H3K4me [6]. On the 
other hand, LSD1 is recruited to the promoter regions of 
androgen receptor (AR) target genes and demethylates 
H3K9me, co-activating AR-dependent transcription [7]. 
Misregulated expression of LSD1 has been reported in 
several cancer types [5, 8].
Our lab reported previously that LSD1 is hyperphos-
phorylated in response to nocodazole-induced meta-
phase arrest [9]. It was demonstrated recently that LSD1 
dissociates from chromatin during mitosis [10]. We 
thus sought to uncover a potential link between LSD1 
and mitotic kinases. Polo-like kinase 1 (PLK1), a major 
mitotic serine/threonine protein kinase, regulates several 
events throughout M phase of the cell cycle, from mitotic 
entry to mitotic exit and cytokinesis [11]. Its functions 
are executed by binding and phosphorylating proteins 
through its polo-box domain and kinase domain, respec-
tively. In this report, we found that PLK1 interacts with 
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and phosphorylates LSD1 at Ser126 and this phospho-
rylation promotes LSD1 release from chromatin during 
mitosis.
Results and discussion
LSD1 directly interacts with PLK1
Our laboratory and others demonstrated previously that 
LSD1 was hyperphosphorylated during mitosis [9]. The 
major mitotic protein kinases include polo-like kinase 1 
(PLK1), CDK1, and CK2. We thus employed inhibitors 
of theses kinases to treat thymidine-nocodazole synchro-
nized HeLa cells (Fig. 1a). We found that PLK1 inhibitor 
treatment, and to a lesser extent, CDK1 inhibitor treat-
ment, reduced thymidine-nocodazole treatment-induced 
retarded migration of LSD1, while CK2 inhibitor treat-
ment did not have such an effect (Fig. 1a). This indicates 
that PLK1 could be one of the kinases for LSD1 phospho-
rylation during mitosis. To confirm this, we performed 
co-immunoprecipitation assays to examine the potential 
interaction between PLK1 and LSD1. It was found that 
endogenous LSD1 was present in the endogenous PLK1 
immunocomplex in 293T cells and vice versa (Fig. 1b). To 
exclude the possibility that this interaction was derived 
from antibody cross-reactivity, HA-LSD1 and FLAG-
PLK1 were co-expressed in 293T cells; subsequent co-
immunoprecipitation assays revealed that HA-LSD1 was 
present in the anti-FLAG immunocomplex and vice versa 
(Fig.  1c). Furthermore, bacterially produced GST-PLK1 
was able to pull down bacterially produced HIS-LSD1 
(Fig. 1d). Taken together, these results demonstrated that 
PLK1 directly interacts with LSD1.
To further dissect this interaction, we generated two 
PLK1 truncation mutants, namely FLAG-PLK1(1-330) 
that harbors the kinase domain and FLAG-PLK1(330-
CT) that contains two polo box domains (Fig. 2a). It was 
found that HA-LSD1 was present in the FLAG-PLK1 
and FLAG-PLK1(330-CT) immunocomplexes, but not 
in the FLAG-PLK1(1-330) immunocomplex (Fig.  2b). 
We also generated several deletion mutants of LSD1 
with a GST epitope (Fig.  3a), and these mutants were 
bacterially expressed, affinity-purified, and applied for 
GST pulldown assays with bacterially produced HIS-
PLK1 (Fig.  3b). It was found that both the mutant with 
deletion of the amino terminus of LSD1 (1-165 aas) and 
the mutant with deletion of the carboxyl terminal AOD 
failed to pull down HIS-PLK1, while the mutant with 
deletion of the SWIRM domain enhanced the pulldown 
of HIS-PLK1 (Fig. 3b). This indicates that both the amino 
terminus and the carboxyl AOD are required for the 
interaction between PLK1 and LSD1.
PLK1 phosphorylates LSD1 at Ser‑126
Given that LSD1 is hyperphosphorylated upon noc-
odazole-induced metaphase arrest [9] and that LSD1 
directly associates with PLK1 (Fig.  1), we reasoned that 
LSD1 could be a substrate of PLK1. In vitro kinase assays 
unveiled that bacterially produced PLK1 efficiently incor-
porated radiolabeled phosphorus-32 into bacterially 
Fig. 1 LSD1 directly interacts with PLK1. a PLK1 inhibitor treatment reduced thymidine‑nocodazole‑induced LSD1 mobility shift in HeLa cells. HeLa 
cells were synchronized at metaphase by single thymidine block followed by nocodazole treatment for 12 h. Kinase inhibitors were added 2 h 
before total cell lysates were harvested. A dash line indicates the center of the shifted band of LSD1. Relative ratio of the unshifted band intensity of 
LSD1/β‑actin was presented. Asy: asynchronized cells; syn: synchronized cells; long exp.: long exposure. b Endogenous LSD1 interacts with PLK1. 
Total cell lysates from 293T cells were subjected to immunoprecipitation followed by immunoblotting with antibodies as indicated. c Ectopic‑
tagged LSD1 interacts with PLK1. FLAG‑PLK1 and HA‑LSD1 were co‑expressed in 293T cells. Total cell lysates were harvested 48 h after transfection 
and subjected to immunoprecipitation followed by immunoblotting with anti‑HA or anti‑FLAG antibodies. d LSD1 directly interacts with PLK1. 
Bacterially produced GST‑PLK1 was used to pull down bacterially produced HIS‑LSD1. Asterisk non‑specific signal
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produced HIS-LSD1 (Fig.  4a). In  vitro phosphorylated 
LSD1 was subjected to trypsin digestion and subsequent 
mass spectrometric analysis, by which a single phos-
phorylation site, namely Ser-126 on LSD1 was identified 
(Fig. 4b). Consistent with the mass spectrometric analysis 
result, mutation of Ser-126 to Ala fully abolished PLK1-
mediated phosphorylation on LSD1, while mutation of 
the adjacent Ser-131 to Ala, which is a CK2-mediated 
phosphorylation site [12], did not have a similar effect 
(Fig. 4a). Sequence alignment of LSD1 from different spe-
cies from human to zebrafish demonstrated that human 
LSD1 Ser-126 residue is well conserved (Fig. 4c), implying 
this phosphorylation site could be functionally relevant. 
To examine if this phosphorylation event occurs in vivo, 
we attempted twice to generate phosphorylation-specific 
LSD1(S126) antibody. However, the affinity-purified IgG 
failed to detect endogenous phosphorylated form of 
LSD1, though it was reactive to in vitro phosphorylated 
form of LSD1 by PLK1 (data not shown). Taken together, 
our results demonstrated that LSD1 is phosphorylated 
by PLK1 at Ser-126, and this phosphorylation site is con-
served in different species.
Phosphorylation of LSD1 by PLK1 promotes its release 
from chromatin during mitosis
We then sought to determine the functional significance 
of PLK1-mediated phosphorylation of LSD1 at Ser-
126. It has been demonstrated that H3K9me3 dramati-
cally increases in G2 to reach a maximum at metaphase, 
maintaining pericentric heterochromatin [13–15]. LSD1 
seems to work with androgen receptor (AR) toward dem-
ethylation of H3K9me1/2 [7], while JMJD2C specifically 
demethylates H3K9me3 [16]. It was further demon-
strated that AR, JMJD2C and LSD1 jointly assemble on 
chromatin to remove methyl groups from mono, di and 
trimethylated H3K9 [17]. It was also reported that LSD1 
dissociates from chromatin during mitosis in embry-
onic stem cells [10]. Therefore, we speculated that LSD1 
would be released from chromatin upon nocodazole-
induced arrest at metaphase in cultured cells. Indeed, 
chromatin fractionation assays found that protein levels 
of LSD1 and its partner CoREST in chromatin-enriched 
fraction declined upon nocodazole treatment (Fig.  5a), 
and this decrease was restored upon pretreatment with 
BI2536, an inhibitor of PLK1 kinase (Fig.  5b). Further-
more, HA-LSD1, but not the phosphorylation-defective 
mutant HA-LSD1(S126A), was reduced in the chromatin 
enriched fraction upon nocodazole treatment (Fig. 5c). It 
was noted that LSD1 retained in the chromatin-enriched 
fraction in response to nocodazole treatment was 
hypophosphorylated, while it was hyperphosphorylated 
in the nuclear soluble fraction (Fig. 5a, b). These findings 
demonstrate that PLK1-mediated phosphorylation of 
LSD1 at Ser-126 promotes LSD1 release from chromatin 
during mitosis.
Histone methylation at specific lysine residues plays a 
critical role in regulating chromatin structure and gene 
expression and subsequent cellular activities. Fine con-
trol of the balance of histone methyltransferase/dem-
ethylase activities is essential for cell cycle progression 
and maintenance of genome integrity [18]. Tipping the 
balance toward either direction could be detrimental. 
For example, LSD1 serves for demethylation of H3K4 
and H3K9 [5], its gene deletion was reported in pancre-
atic ductal adenocarcinoma (7/109 = 6.4%) [19], while its 
gene amplification was found in neuroendocrine prostate 
cancer (6/107 =  5.6%) (http://www.cbioportal.org/) and 
sarcoma (6/207 = 2.9%) [20]. LSD1 RNA expression lev-
els vary a lot in different cancer types (http://www.cbio-
portal.org/). These findings imply that a delicate control 
of LSD1 expression levels, subcellular localization, and 
enzymatic activity may be a requirement for genome 
stability. Whole-genome mapping demonstrated that 
Fig. 2 The Polo‑box domains of PLK1 mediate its interaction with 
LSD1. a Domain structure of PLK1. PLK1 encodes a polypeptide of 
603 AAs. Its amino terminus (1‑330 AAs) contains the kinase domain, 
while its carboxyl terminus (330‑CT) harbors two Polo boxes. b Car‑
boxyl terminus of PLK1 mediated its interaction with LSD1. HA‑LSD1 
and wild‑type FLAG‑PLK1 or its truncation mutants were transiently 
co‑expressed in 293T cells, total cell lysates were harvested 48 h after 
transfection and subjected to immunoprecipitation followed by 
immunoblotting with antibodies as indicated
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LSD1 genomic regions overlaps with H3K4me2 genomic 
regions and both are enriched on the promoters of highly 
expressed genes in ES cells [10], while H3K9me3 lev-
els peak at the pericentromeric regions during mitosis 
[13–15]. To reduce general transcriptional activity to a 
minimum and maintain high H3K9me3 levels at the peri-
centromeric regions during mitosis, histone demethylase 
activities on chromatin should be reduced.
Conclusions
Our study has uncovered a novel regulatory mechanism 
for controlling histone demethylase activity, in which 
PLK1-mediated phosphorylation of LSD1 during mitosis 
expels it from chromatin.
Methods
Cell cultures, reagents, antibodies
HeLa and HEK293T cells were grown in high-glucose 
Dulbecco’s Modified Eagle’s Medium (DMEM) supple-
mented with 10% fetal bovine serum at a 37 °C incubator 
with 5% CO2.
Nocodazole (M1404, a final concentration of 340  nM 
was used throughout this research) and Thymidine 
(T1895, a final concentration of 2  mM was used) were 
purchased from Sigma. BI2536, a PLK1 inhibitor (S1109, 
a final concentration of 1 μM was used), was purchased 
from Selleck.
Rabbit polyclonal antibodies used for immunoblotting 
and immunoprecipitation in this study including anti-HA 
(A190–208A), anti-LSD1 (A300–215A), anti-CoREST 
(A300–130A), anti-GAPDH (A300–643A) and anti-
H3 Ser10 (A301–844A) were from Bethyl Laboratories. 
Rabbit polyclonal anti-H3 antibody (#9715) was from 
Cell Signaling Technology. Mouse monoclonal antibody 
against GST (A00865) was from GenScript Corporation. 
Mouse monoclonal anti-FLAG M2 (F1804) was from 
Sigma. Mouse monoclonal anti-HIS (D291-3) was from 
MBL Biotech.
Expression constructs
Human cDNA clones encoding full length and deletion 
mutants of LSD1, PLK1 were subcloned into pcDNA3.0 
with three copies of HA or FLAG epitope at its N-termi-
nus for expression in mammalian cells or into pET28(A) 
or pGEX-4T-1 for producing HIS or GST recombinant 
fusion protein in E. coli. Point mutants (LSD1(S126A), 
LSD1(S131A), and LSD1(2A)) were generated using the 
QuikChange mutagenesis kit (SBS Genetech Co).
Immunoblotting and immunoprecipitation
Both immunoblotting and immunoprecipitation assays 
were performed with desired antibodies according to the 
protocols described before [12, 21].
GST‑pulldown and in vitro kinase assay
Bacterially-purified GST fusions (1  μg) were incubated 
with bacterially produced HIS tagged fusions (1  μg) in 
500  μl of NETN buffer at 4  °C overnight. Glutathione-
Sepharose beads (20  μl per pulldown) were added and 
incubated for 1 h before extensively washing with NETN 
buffer.
Fig. 3 Both amino terminus and carboxyl terminus of LSD1 are 
important for its interaction with PLK1. a Schematic diagram of LSD1. 
LSD1 encodes a polypeptide of 852 AAs with a SWIRM domain, a 
TOWER domain in between an amino amine oxidase (AOD) domain 
(AOD‑N) and a carboxyl AOD domain (AOD‑C). NT amino terminus; 
CT carboxyl terminus. b Both NT and CT of LSD1 are important for 
its direct interaction with PLK1. Bacterially produced GST fusions of 
LSD1 and its deletion mutants were used to pull down bacterially 
produced HIS‑PLK1. An arrow points to the target protein
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For in  vitro kinase assays [12, 22], bacterially-purified 
HIS tagged PLK1 and LSD1 were incubated at kinase 
buffer containing 50 mM HEPES (pH 7.4), 10 mM MgCl2, 
1 mM DTT, 1 mM Na3VO4, 10 μM coldATP and 5 μCi 
[γ-32P]-ATP at 30 °C for 30 min.
Identification of phosphorylation sites of LSD1 by PLK1 
using mass spectrometry
Phosphorylation site mapping by mass spectrometry was 
performed as described previously [23]. Briefly, in  vitro 
phosphorylated proteins were precipitated with TCA and 
resuspended in a buffer containing 8  M urea, 100  mM 
Tris, pH8.5. After reduction and alkylation, the sample 
was digested by Trypsin overnight at 37 °C. The peptides 
were analyzed on an Easy-nLC 1000 UPLC (Thermo 
Fisher Scientific) coupled to a Q exactive mass spectrom-
eter (Thermo Fisher Scientific). Peptides were loaded on 
a pre-column (75 μm ID and packed with 8 cm ODS-AQ 
12  nM S-10  mm (YMC Co., Ltd)) and separated on an 
analytical column (75 μm ID and packed with 11 cm Luna 
3 μm 100Å resin (Phenomenex)) with an acetonitrile gra-
dient from 0 to 30% in 55  min and 30–80% in another 
10 min at a flow rate of 300 nl/min. Spectra were acquired 
in a data-dependent mode: the 10 most intense ions except 
charge 1+ or unassigned from each full scan (Resolution 
70,000) were isolated for HCD MS2 (Resolution 17,500) at 
NEC 27 with a dynamic exclusion time of 60 s. For pep-
tide identification, the MS2 spectra were searched against 
an artificial database (including GST-LSD1 and HIS-PLK1 
sequences in a C. elegans WS217 database) using Prolucid 
[24]. Search results were filtered using DTASelect 2.0 [25] 
with 7 p.p.m. mass accuracy for precursor mass and a 5% 
FDR cutoff. The phosphorylation spectra presented in the 
figures were annotated using pLabel [26].
Chromatin fractionation and cell synchronization
Chromatin fractionation was performed essentially as 
described before [21]. HeLa and HEK293 cells were 
Fig. 4 PLK1 phosphorylates LSD1 at Ser‑126. a PLK1 phosphorylates LSD1 in vitro. In vitro kinase assays in the presence of 32P‑ATP were performed 
by incubating bacterially produced HIS‑PLK1 with HIS‑LSD1 or its point mutants. b Mass spectrometry analysis identified Ser126 as the confident 
phosphorylation sites of LSD1 by PLK1. In vitro phosphorylated LSD1 by PLK1 with cold ATP was subjected to trypsin digestion and mass spectro‑
metric analysis. c Ser126 of human LSD1 is conserved from human to zebrafish. Polypeptides surrounding the Ser‑126 site from different species 
were aligned
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synchronized at metaphase by thymidine-nocodazole 
block as described before [27].
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